SOPHiA GENETICS (SOPH) Free Cash Flow (2020 - 2025)

SOPHiA GENETICS has disclosed Free Cash Flow across 6 years of filings, most recently posting -$7.8 million for Q4 2025.

• Free Cash Flow for Q4 2025 came in at -$7.8 million, up 25.45% year-over-year; the trailing twelve-month figure through Dec 2025 was -$35.1 million (up 19.7% YoY), and the FY2025 annual result was -$35.1 million, up 19.7% from the prior year.
• Free Cash Flow came in at -$7.8 million for Q4 2025 at SOPHiA GENETICS, up from -$8.6 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of -$7.8 million in Q4 2025 to a low of -$22.2 million in Q3 2022.
• The 5-year median for Free Cash Flow is -$11.4 million (2023), against an average of -$12.6 million.
• Across the five-year window, Free Cash Flow tumbled 67.01% in 2022 and surged 45.85% in 2023, its largest moves.
• SOPHiA GENETICS's Free Cash Flow stood at -$15.3 million in 2021, then surged by 40.73% to -$9.0 million in 2022, then tumbled by 37.3% to -$12.4 million in 2023, then increased by 15.77% to -$10.5 million in 2024, then increased by 25.45% to -$7.8 million in 2025.
• The last three Free Cash Flow figures came in at -$7.8 million (Q4 2025), -$8.6 million (Q3 2025), and -$9.4 million (Q2 2025), per Business Quant data.